tiprankstipranks
uniQure N.V. (QURE)
NASDAQ:QURE
US Market
QURE
uniQure
RESEARCH TOOLSreports
Want to see QURE full AI Analyst Report?

uniQure (QURE) Stock Forecast & Price Target

1,479 Followers
See the Price Targets and Ratings of:

QURE Analyst Ratings

Strong Buy
11Ratings
Strong Buy
10 Buy
1 Hold
0 Sell
Based on 11 analysts giving stock ratings to
uniQure
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

QURE Stock 12 Month Forecast

Average Price Target

$59.33
▲(237.50% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for uniQure in the last 3 months. The average price target is $59.33 with a high forecast of $95.00 and a low forecast of $35.00. The average price target represents a 237.50% change from the last price of $17.58.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"$9","96":"$96","30.75":"$30.8","52.5":"$52.5","74.25":"$74.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$95.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":59.333333333333336,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$59.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$35.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,30.75,52.5,74.25,96],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.22,33.356923076923074,38.49384615384615,43.63076923076923,48.76769230769231,53.90461538461538,59.041538461538465,64.17846153846153,69.31538461538462,74.4523076923077,79.58923076923077,84.72615384615385,89.86307692307693,{"y":95,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.22,30.613333333333333,33.00666666666667,35.4,37.79333333333334,40.18666666666667,42.58,44.97333333333333,47.36666666666667,49.760000000000005,52.153333333333336,54.54666666666667,56.94,{"y":59.333333333333336,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,28.22,28.74153846153846,29.263076923076923,29.784615384615385,30.306153846153844,30.827692307692306,31.34923076923077,31.87076923076923,32.39230769230769,32.91384615384615,33.43538461538461,33.956923076923076,34.47846153846154,{"y":35,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.485,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.99,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.695,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.01,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.99,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.69,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.57,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.93,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.7,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.5,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.89,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.13,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.22,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$95.00Average Price Target$59.33Lowest Price Target$35.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on QURE
Eliana Merle
Barclays
Barclays
$25→$65
Buy
269.74%
Upside
Upgraded
06/22/26
Positive Report for uniQure (QURE) from Barclays
Stifel Nicolaus Analyst forecast on QURE
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$28→$71
Buy
303.87%
Upside
Reiterated
06/21/26
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), uniQure (QURE)
H.C. Wainwright Analyst forecast on QURE
Patrick Trucchio
H.C. Wainwright
H.C. Wainwright
$50
Buy
184.41%
Upside
Reiterated
06/18/26
uniQure AMT-130 update 'materially positive,' says H.C. WainwrightuniQure AMT-130 update 'materially positive,' says H.C. Wainwright
RBC Capital Analyst forecast on QURE
Luca Issi
RBC Capital
RBC Capital
$35→$65
Buy
269.74%
Upside
Reiterated
06/18/26
uniQure price target raised to $65 from $35 at RBC CapitaluniQure price target raised to $65 from $35 at RBC Capital
Leerink Partners Analyst forecast on QURE
Joseph Schwartz
Leerink Partners
Leerink Partners
$36→$70
Buy
298.18%
Upside
Reiterated
06/17/26
Analysts Are Bullish on These Healthcare Stocks: uniQure (QURE), Biohaven Ltd. (BHVN)
TD Cowen Analyst forecast on QURE
Joseph Thome
TD Cowen
TD Cowen
―
Buy
―
Reiterated
06/17/26
TD Cowen Sticks to Their Buy Rating for uniQure (QURE)
Cantor Fitzgerald Analyst forecast on QURE
Kristen Kluska
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Upgraded
06/17/26
uniQure upgraded to Overweight from Neutral at Cantor FitzgeralduniQure upgraded to Overweight from Neutral at Cantor Fitzgerald
Goldman Sachs Analyst forecast on QURE
Salveen Richter
Goldman Sachs
Goldman Sachs
$14→$46
Hold
161.66%
Upside
Assigned
06/17/26
uniQure price target raised to $46 from $14 at Goldman SachsuniQure price target raised to $46 from $14 at Goldman Sachs
Guggenheim Analyst forecast on QURE
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$95
Buy
440.39%
Upside
Reiterated
05/05/26
Guggenheim Sticks to Their Buy Rating for uniQure (QURE)
Chardan Capital Analyst forecast on QURE
Daniil Gataulin
Chardan Capital
Chardan Capital
$37
Buy
110.47%
Upside
Reiterated
05/05/26
Chardan Capital Remains a Buy on uniQure (QURE)
Mizuho Securities Analyst forecast on QURE
Uy Ear
Mizuho Securities
Mizuho Securities
$35
Buy
99.09%
Upside
Reiterated
05/05/26
Analysts' Top Healthcare Picks: Spyre Therapeutics (SYRE), uniQure (QURE)
Wells Fargo Analyst forecast on QURE
Yanan Zhu
Wells Fargo
Wells Fargo
$15→$60
Buy
241.30%
Upside
Upgraded
03/09/26
uniQure upgraded to Overweight from Equal Weight at Wells FargouniQure upgraded to Overweight from Equal Weight at Wells Fargo
Wolfe Research Analyst forecast on QURE
Rudy Li
Wolfe Research
Wolfe Research
―
Hold
―
Initiated
02/23/26
uniQure initiated with a Peer Perform at Wolfe ResearchuniQure initiated with a Peer Perform at Wolfe Research
William Blair Analyst forecast on QURE
Sami Corwin
William Blair
William Blair
―
Hold
―
Reiterated
02/06/26
Balanced Risk/Reward at uniQure: Early Promise for AMT-191 Offset by Regulatory and Competitive Uncertainty Around AMT-130
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on QURE
Eliana Merle
Barclays
Barclays
$25→$65
Buy
269.74%
Upside
Upgraded
06/22/26
Positive Report for uniQure (QURE) from Barclays
Stifel Nicolaus Analyst forecast on QURE
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$28→$71
Buy
303.87%
Upside
Reiterated
06/21/26
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), uniQure (QURE)
H.C. Wainwright Analyst forecast on QURE
Patrick Trucchio
H.C. Wainwright
H.C. Wainwright
$50
Buy
184.41%
Upside
Reiterated
06/18/26
uniQure AMT-130 update 'materially positive,' says H.C. WainwrightuniQure AMT-130 update 'materially positive,' says H.C. Wainwright
RBC Capital Analyst forecast on QURE
Luca Issi
RBC Capital
RBC Capital
$35→$65
Buy
269.74%
Upside
Reiterated
06/18/26
uniQure price target raised to $65 from $35 at RBC CapitaluniQure price target raised to $65 from $35 at RBC Capital
Leerink Partners Analyst forecast on QURE
Joseph Schwartz
Leerink Partners
Leerink Partners
$36→$70
Buy
298.18%
Upside
Reiterated
06/17/26
Analysts Are Bullish on These Healthcare Stocks: uniQure (QURE), Biohaven Ltd. (BHVN)
TD Cowen Analyst forecast on QURE
Joseph Thome
TD Cowen
TD Cowen
―
Buy
―
Reiterated
06/17/26
TD Cowen Sticks to Their Buy Rating for uniQure (QURE)
Cantor Fitzgerald Analyst forecast on QURE
Kristen Kluska
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Upgraded
06/17/26
uniQure upgraded to Overweight from Neutral at Cantor FitzgeralduniQure upgraded to Overweight from Neutral at Cantor Fitzgerald
Goldman Sachs Analyst forecast on QURE
Salveen Richter
Goldman Sachs
Goldman Sachs
$14→$46
Hold
161.66%
Upside
Assigned
06/17/26
uniQure price target raised to $46 from $14 at Goldman SachsuniQure price target raised to $46 from $14 at Goldman Sachs
Guggenheim Analyst forecast on QURE
Unknown Analyst
Guggenheim
Not Ranked
Guggenheim
$95
Buy
440.39%
Upside
Reiterated
05/05/26
Guggenheim Sticks to Their Buy Rating for uniQure (QURE)
Chardan Capital Analyst forecast on QURE
Daniil Gataulin
Chardan Capital
Chardan Capital
$37
Buy
110.47%
Upside
Reiterated
05/05/26
Chardan Capital Remains a Buy on uniQure (QURE)
Mizuho Securities Analyst forecast on QURE
Uy Ear
Mizuho Securities
Mizuho Securities
$35
Buy
99.09%
Upside
Reiterated
05/05/26
Analysts' Top Healthcare Picks: Spyre Therapeutics (SYRE), uniQure (QURE)
Wells Fargo Analyst forecast on QURE
Yanan Zhu
Wells Fargo
Wells Fargo
$15→$60
Buy
241.30%
Upside
Upgraded
03/09/26
uniQure upgraded to Overweight from Equal Weight at Wells FargouniQure upgraded to Overweight from Equal Weight at Wells Fargo
Wolfe Research Analyst forecast on QURE
Rudy Li
Wolfe Research
Wolfe Research
―
Hold
―
Initiated
02/23/26
uniQure initiated with a Peer Perform at Wolfe ResearchuniQure initiated with a Peer Perform at Wolfe Research
William Blair Analyst forecast on QURE
Sami Corwin
William Blair
William Blair
―
Hold
―
Reiterated
02/06/26
Balanced Risk/Reward at uniQure: Early Promise for AMT-191 Offset by Regulatory and Competitive Uncertainty Around AMT-130
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering uniQure

3 Months
Joseph ThomeTD Cowen
Success Rate
13/21 ratings generated profit
62%
Average Return
+44.52%
Copying Joseph Thome's trades and holding each position for 3 Months would result in 61.90% of your transactions generating a profit, with an average return of +44.52% per trade.
1 Year
Patrick TrucchioH.C. Wainwright
Success Rate
18/21 ratings generated profit
86%
Average Return
+112.04%
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +112.04% per trade.
2 Years
Patrick TrucchioH.C. Wainwright
Success Rate
19/21 ratings generated profit
90%
Average Return
+246.97%
Copying Patrick Trucchio's trades and holding each position for 2 Years would result in 90.48% of your transactions generating a profit, with an average return of +246.97% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QURE Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
9
13
13
16
9
Buy
2
4
4
4
9
Hold
4
10
10
10
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
27
27
30
22
In the current month, QURE has received 18 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. QURE average Analyst price target in the past 3 months is 59.33.
Each month's total comprises the sum of three months' worth of ratings.

QURE Financial Forecast

QURE Earnings Forecast

Next quarter’s earnings estimate for QURE is -$0.84 with a range of -$0.94 to -$0.76. The previous quarter’s EPS was -$0.85. QURE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year QURE has Performed in-line its overall industry.
Next quarter’s earnings estimate for QURE is -$0.84 with a range of -$0.94 to -$0.76. The previous quarter’s EPS was -$0.85. QURE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year QURE has Performed in-line its overall industry.

QURE Sales Forecast

Next quarter’s sales forecast for QURE is $5.49M with a range of $2.30M to $10.00M. The previous quarter’s sales results were $3.56M. QURE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year QURE has Performed in-line its overall industry.
Next quarter’s sales forecast for QURE is $5.49M with a range of $2.30M to $10.00M. The previous quarter’s sales results were $3.56M. QURE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year QURE has Performed in-line its overall industry.

QURE Stock Forecast FAQ

What is QURE’s average 12-month price target, according to analysts?
Based on analyst ratings, uniQure N.V.’s 12-month average price target is 59.33.
    What is QURE’s upside potential, based on the analysts’ average price target?
    uniQure N.V. has 237.50% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is QURE a Buy, Sell or Hold?
          uniQure N.V. has a consensus rating of Strong Buy which is based on 10 buy ratings, 1 hold ratings and 0 sell ratings.
            What is uniQure N.V.’s price target?
            The average price target for uniQure N.V. is 59.33. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $95.00 ,the lowest forecast is $35.00. The average price target represents 237.50% Increase from the current price of $17.58.
              What do analysts say about uniQure N.V.?
              uniQure N.V.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of QURE?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.